Table 1.
Population | Special concern | Choice of BI | Titration | Additional GLAs |
---|---|---|---|---|
Fasting/Ramadan | Hypoglycemia | Gla-100/Gla-300/degludec | Slow | DPP4i/TZD/glipizide/repaglinide |
Pregnancy | Safety | NPH/Detemir/Glargine | Early titration until target | Metformin |
Elderly | Hypoglycemia | Gla-100/Gla-300/degludec | Slow/weekly | DPP4i/metformin/SU |
BI basal insulin, DPP4i dipeptidyl peptidase-4 inhibitor, NPH neutral protamine Hagedorn, GLA oral glucose-lowering agents, TZD thiazolidinediones, SU sulfonylureas